Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitis and emphysema, and current drug treatments target its symptoms. Thus, the development of a therapeutic drug to repair alveolar destruction is urgently needed. Our previous research revealed that the synthetic retinoic acid Am80 (1.0 mg/kg) showed a repairing effect on collapsed alveoli in a mouse model of elastase-induced emphysema. However, a further reduction in the dose is desirable to facilitate the development of a powder inhalation formulation for clinical application. We, therefore, focused on SS-OP to deliver Am80 efficiently. As a result, 0.01 mg/kg of Am80-encapsulated SS-OP nanoparticles repaired collapsed alveoli and improved the respiratory function in the mouse model of elastase induced emphysema. The results suggested that, with the use of SS-OP, the Am80 dose could be reduced. This could contribute to the development of a powder inhalation system as a curative medicine for COPD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860907 | PMC |
| http://dx.doi.org/10.3390/pharmaceutics15010037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intrathoracic oxygen detects alveolar air leak following video-assisted thoracoscopic lung resection.
Sci Rep
August 2025
Department of Thoracic Surgery, St. Marianna University School of Medicine, 2-16-1, Sugao, Kanagawa, Kawasaki, 216-8511, Japan.
The water submersion test (W-test) has the risk of overlooking air leaks during lung resection. We assessed the relationship between alveolar air leakage and intrathoracic gas concentrations as a novel intraoperative air leak detection method. We compared the W-test results with intrathoracic gas concentrations of desflurane, oxygen (O2), and carbon dioxide (CO2), prospectively measured using a gas analyser built-in into the anaesthesia machine before and after lung resection.
View Article and Find Full Text PDFComparative Efficacy and Safety Profile of the Combination of Pulmonary Surfactant and Budesonide vs. Surfactant Alone in the Management of Neonatal Respiratory Distress Syndrome: An Updated Meta-Analysis.
Medicina (Kaunas)
July 2025
Department of Medicine, National heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.
Neonatal respiratory distress syndrome (NRDS), resulting from a deficiency of pulmonary surfactant (PS), can cause alveoli to collapse. Glucocorticoids reduce inflammation and are effective in reducing pulmonary swelling. This study aims to assess the effectiveness of the combination of PS and budesonide in the management of NRDS.
View Article and Find Full Text PDFA computational physiological model of acute respiratory distress syndrome patients for positive end-expiratory pressure titration.
Comput Biol Med
August 2025
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy; Polito BioMed Lab, Politecnico di Torino, Turin, Italy.
Background And Objective: Patients with acute respiratory distress syndrome (ARDS) experience alveolar collapse, leading to reduced ventilation and blood oxygenation. Clinical treatment with mechanical ventilation involves the use of positive end-expiratory pressure (PEEP) to recruit collapsed alveoli. The identification of an optimal PEEP level has remained a subject of debate in critical care for over 50 years.
View Article and Find Full Text PDFPlatelet-Rich Plasma (PRP) Mitigates Silver Nanoparticle (AgNP)-Induced Pulmonary Fibrosis via iNOS/CD68/CASP3/TWIST1 Regulation: An Experimental Study and Bioinformatics Analysis.
Int J Mol Sci
July 2025
Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia 11566, Cairo, Egypt.
Platelet-rich plasma (PRP) has become an increasingly valuable biologic approach for personalized regenerative medicine because of its potent anti-inflammatory/healing effects. It is thought to be an excellent source of growth factors that can promote tissue healing and lessen fibrosis. Although this treatment has demonstrated effectiveness in numerous disease areas, its impact on pulmonary fibrosis (PF) caused by silver nanoparticles (AgNPs) via its antiapoptotic effects remains to be explored.
View Article and Find Full Text PDFSubcutaneous and mediastinal emphysema after lobectomy: Two case reports with different courses.
Int J Surg Case Rep
September 2025
Department of Thoracic and Cardiovascular Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Introduction: Subcutaneous and mediastinal emphysema after lobectomy is uncommon and is typically caused by minor air leakage from the residual lung; however, the development of a contralateral pneumothorax is particularly rare, and if missed, it can be fatal.
Presentation Of Cases: Two cases of subcutaneous and mediastinal emphysema occurring after a lobectomy in a 77-year-old man and a 78-year-old man are reported here. The former received conservative treatment, while the latter he developed a pneumothorax on the side contralateral to the surgical site after readmission.